Directory

>

Shingai Majuru

avatar

Shingai Majuru

Vice President, Head of CMC, Small Molecule Development | Roivant Sciences

United States

View contact details (it's free)

Shingai Majuru

Summary

Shingai Majuru is a seasoned pharmaceutical development executive with extensive experience in Chemistry, Manufacturing and Controls (CMC) within the biopharmaceutical sector. He currently serves as the Vice President and Head of CMC for Small Molecule Development at Roivant Sciences, where he leads strategic evaluations and global development strategies for in-licensing opportunities. His expertise encompasses a broad spectrum of CMC activities, including formulation development, regulatory documentation, and technology transfer. Shingai has a strong academic background, holding advanced degrees in Pharmaceutics and Business. He has contributed to numerous publications in the field, reflecting his commitment to advancing pharmaceutical sciences. His leadership style is characterized by a hands-on approach, fostering teamwork and innovation. Shingai's diverse experience spans both startup and corporate environments, allowing him to navigate complex challenges in drug development effectively.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Shingai Majuru

Work Experience

company logo

Vice President, Head of CMC, Small Molecule Development at

Roivant Sciences

August 2017 - Present

company logo

Head of CMC, Drug Product Development at

ROIVANT SCIENCES LTD.

July 2018 - April 2021

company logo

Senior Director, Drug Formulation Development at

ROIVANT SCIENCES LTD.

August 2017 - July 2018

company logo

Independent Consultant at

Jsm Pharmaceutical Consulting, LLC

January 2012 - August 2017

company logo

Executive Director, Oral Products Development at

Cempra Pharmaceuticals

February 2013 - February 2017

💼

Director, Pharmaceutical Development at

BIOCRYST IRELAND LIMITED

March 2012 - January 2013

company logo

Director, Formulations Development at

Banner Pharmacaps

July 2008 - January 2012

💼

Senior Director, Pharmaceutics R&D at

Emisphere Technologies

October 1997 - July 2008

company logo

Post Doctoral Fellow at

The University of Iowa

December 1996 - October 1997

Logos provided by Logo.dev

Shingai Majuru

Education

Western Connecticut State University, Mba

January 2006 - January 2009

University of Iowa, Ph.D.

January 1991 - January 1996

University of Iowa, Msc.

January 1991 - January 1994

University of Zimbabwe, M.Phil

January 1988 - January 1991

University of Zimbabwe, B.Pharm.(Hons.)

January 1985 - January 1987

Frequently Asked Questions about Shingai Majuru

What is Shingai Majuru email address?

Shingai Majuru's primary email address is **************@roivant.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Shingai Majuru work for?

Shingai Majuru is a Vice President, Head of CMC, Small Molecule Development at Roivant Sciences.

Where Shingai Majuru graduated from?

Shingai Majuru holds a degree in Business from Western Connecticut State University.

How can I directly contact Shingai Majuru?

To contact Shingai Majuru directly, you can use the email address **************@roivant.com. Complete contact information is available upon registration with Muraena.

Is Shingai Majuru an immigrant?

Yes, Shingai Majuru is an immigrant and currently based in United States

Who is Shingai Majuru?

Shingai Majuru is a seasoned pharmaceutical development executive with extensive experience in Chemistry, Manufacturing and Controls (CMC) within the biopharmaceutical sector. He currently serves as the Vice President and Head of CMC for Small Molecule Development at Roivant Sciences, where he leads strategic evaluations and global development strategies for in-licensing opportunities. His expertise encompasses a broad spectrum of CMC activities, including formulation development, regulatory documentation, and technology transfer. Shingai has a strong academic background, holding advanced degrees in Pharmaceutics and Business. He has contributed to numerous publications in the field, reflecting his commitment to advancing pharmaceutical sciences. His leadership style is characterized by a hands-on approach, fostering teamwork and innovation. Shingai's diverse experience spans both startup and corporate environments, allowing him to navigate complex challenges in drug development effectively.

Shingai`s contact details

mail

**************@roivant.com

Colleagues

avatar
Srini Ramanathan

Chief Development Officer

avatar
Paul Davis

Chief Communications Officer

avatar
Richard Pulik

Chief Financial Officer

avatar
Sudhir Penugonda

Executive Director

avatar
Stephanie Lee Griffin

VP, Special Projects, Office of CEO

avatar
Drew Fromkin

Chief Executive Officer

Eric Valeur

VP, Research

Keith Haan

Senior Vice President, Investments

avatar
Daniel Patterson

Vice President, Head of CMC, Biologics and Gene Therapies

View Contact details (it's free)
Request Profile Removal